AAAAAA

   
Results: 1-12 |
Results: 12
Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents
Authors: Newton, DL Hansen, HJ Liu, HT Ruby, D Iordanov, MS Magun, BE Goldenberg, DM Rybak, SM
Citation: Dl. Newton et al., Specifically targeting the CD22 receptor of human B-cell lymphomas with RNA damaging agents, CR R ONC H, 39(1-2), 2001, pp. 79-86
RNA damage and inhibition of neoplastic endothelial cell growth: Effects of human and amphibian ribonucleases
Authors: Newton, DL Kaur, G Rhim, JS Sausville, EA Rybak, SM
Citation: Dl. Newton et al., RNA damage and inhibition of neoplastic endothelial cell growth: Effects of human and amphibian ribonucleases, RADIAT RES, 155(1), 2001, pp. 171-174
Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma
Authors: Newton, DL Hansen, HJ Mikulski, SM Goldenberg, DM Rybak, SM
Citation: Dl. Newton et al., Potent and specific antitumor effects of an anti-CD22-targeted cytotoxic ribonuclease: potential for the treatment of non-Hodgkin lymphoma, BLOOD, 97(2), 2001, pp. 528-535
A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3 ' UTR of unusual length and structure
Authors: Chen, SL Le, SY Newton, DL Maizel, JV Rybak, SM
Citation: Sl. Chen et al., A gender-specific mRNA encoding a cytotoxic ribonuclease contains a 3 ' UTR of unusual length and structure, NUCL ACID R, 28(12), 2000, pp. 2375-2382
Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis
Authors: Iordanov, MS Ryabinina, OP Wong, J Dinh, TH Newton, DL Rybak, SM Magun, BE
Citation: Ms. Iordanov et al., Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: Evidence for cytotoxic mechanisms different from inhibition of protein synthesis, CANCER RES, 60(7), 2000, pp. 1983-1994
Preparation and preclinical characterization of RNase-based immunofusion proteins
Authors: Newton, DL Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Preparation and preclinical characterization of RNase-based immunofusion proteins, METH MOL B, 160, 2000, pp. 387-406
Construction of ribonuclease-antibody conjugates for selective cytotoxicity
Authors: Newton, DL Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Construction of ribonuclease-antibody conjugates for selective cytotoxicity, METH MOL M, 25, 2000, pp. 27-35
Preparation of recombinant RNase single-chain antibody fusion proteins
Authors: Newton, DL Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Preparation of recombinant RNase single-chain antibody fusion proteins, METH MOL M, 25, 2000, pp. 77-95
Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice
Authors: Newton, DL Pollock, D DiTullio, P Echelard, Y Harvey, M Wilburn, B Williams, J Hoogenboom, HR Raus, JCM Meade, HM Rybak, SM
Citation: Dl. Newton et al., Antitransferrin receptor antibody-RNase fusion protein expressed in the mammary gland of transgenic mice, J IMMUNOL M, 231(1-2), 1999, pp. 159-167
Natural and engineered cytotoxic ribonucleases: Therapeutic potential
Authors: Rybak, SM Newton, DL
Citation: Sm. Rybak et Dl. Newton, Natural and engineered cytotoxic ribonucleases: Therapeutic potential, EXP CELL RE, 253(2), 1999, pp. 325-335
Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases
Authors: Smith, MR Newton, DL Mikulski, SM Rybak, SM
Citation: Mr. Smith et al., Cell cycle-related differences in susceptibility of NIH/3T3 cells to ribonucleases, EXP CELL RE, 247(1), 1999, pp. 220-232
Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth
Authors: Newton, DL Rybak, SM
Citation: Dl. Newton et Sm. Rybak, Unique recombinant human ribonuclease and inhibition of Kaposi's sarcoma cell growth, J NAT CANC, 90(23), 1998, pp. 1787-1791
Risultati: 1-12 |